132 related articles for article (PubMed ID: 27671746)
1. The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based analysis.
Bakens MJ; van der Geest LG; van Putten M; van Laarhoven HW; Creemers GJ; Besselink MG; Lemmens VE; de Hingh IH;
Cancer Med; 2016 Oct; 5(10):2825-2831. PubMed ID: 27671746
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Adjuvant Chemotherapy Following Pancreaticoduodenectomy in Elderly Patients With Pancreatic Cancer.
Shin SH; Park Y; Hwang DW; Song KB; Lee JH; Kwon J; Yoo C; Alshammary S; Kim SC
Anticancer Res; 2019 Feb; 39(2):1005-1012. PubMed ID: 30711988
[TBL] [Abstract][Full Text] [Related]
3. Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population-based study.
van der Geest LGM; van Eijck CHJ; Groot Koerkamp B; Lemmens VEPP; Busch OR; Vissers PAJ; Wilmink JW; Besselink MG;
Cancer Med; 2018 Oct; 7(10):4943-4951. PubMed ID: 30188015
[TBL] [Abstract][Full Text] [Related]
4. Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma.
Nussbaum DP; Adam MA; Youngwirth LM; Ganapathi AM; Roman SA; Tyler DS; Sosa JA; Blazer DG
Ann Surg Oncol; 2016 Mar; 23(3):1026-33. PubMed ID: 26542590
[TBL] [Abstract][Full Text] [Related]
5. Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer.
van der Geest LGM; Haj Mohammad N; Besselink MGH; Lemmens VEPP; Portielje JEA; van Laarhoven HWM; Wilmink JHW;
Cancer Med; 2017 Dec; 6(12):2840-2849. PubMed ID: 29035014
[TBL] [Abstract][Full Text] [Related]
6. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head.
Lutfi W; Talamonti MS; Kantor O; Wang CH; Liederbach E; Stocker SJ; Bentrem DJ; Roggin KK; Winchester DJ; Marsh R; Prinz RA; Baker MS
Surgery; 2016 Sep; 160(3):714-24. PubMed ID: 27422328
[TBL] [Abstract][Full Text] [Related]
7. Socio-economic status influences the likelihood of undergoing surgical treatment for pancreatic cancer in the Netherlands.
Bakens MJAM; Lemmens VEPP; de Hingh IHJT
HPB (Oxford); 2017 May; 19(5):443-448. PubMed ID: 28223043
[TBL] [Abstract][Full Text] [Related]
8. Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis.
Beger HG; Gansauge F; Büchler MW; Link KH
World J Surg; 1999 Sep; 23(9):946-9. PubMed ID: 10449825
[TBL] [Abstract][Full Text] [Related]
9. Elderly Patients Strongly Benefit from Centralization of Pancreatic Cancer Surgery: A Population-Based Study.
van der Geest LG; Besselink MG; Busch OR; de Hingh IH; van Eijck CH; Dejong CH; Lemmens VE
Ann Surg Oncol; 2016 Jun; 23(6):2002-9. PubMed ID: 26795767
[TBL] [Abstract][Full Text] [Related]
10. Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer.
Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
Cancer; 2016 Oct; 122(19):2979-87. PubMed ID: 27328270
[TBL] [Abstract][Full Text] [Related]
11. Ten weeks to live: a population-based study on treatment and survival of patients with metastatic pancreatic cancer in the south of the Netherlands.
Bernards N; Haj Mohammad N; Creemers GJ; de Hingh IH; van Laarhoven HW; Lemmens VE
Acta Oncol; 2015 Mar; 54(3):403-10. PubMed ID: 25263080
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma.
Shinkawa H; Uenishi T; Takemura S; Sakata C; Urata Y; Nozawa A; Hamano G; Kinoshita M; Kubo S
Hepatogastroenterology; 2015; 62(137):169-74. PubMed ID: 25911890
[TBL] [Abstract][Full Text] [Related]
13. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
[TBL] [Abstract][Full Text] [Related]
14. Impact of network treatment in patients with resected pancreatic cancer on use and timing of chemotherapy and survival.
Hopstaken JS; Vissers PAJ; Quispel R; de Vos-Geelen J; Brosens LAA; de Hingh IHJT; van der Geest LG; Besselink MG; van Laarhoven KJHM; Stommel MWJ
BJS Open; 2023 May; 7(3):. PubMed ID: 37151083
[TBL] [Abstract][Full Text] [Related]
15. Age as a prognostic indicator for adjuvant therapy in patients who underwent pancreatic resections for cancer.
Eubanks A; Pepe J; Veldhuis P; de la Fuente SG
J Geriatr Oncol; 2018 Jul; 9(4):362-366. PubMed ID: 29330039
[TBL] [Abstract][Full Text] [Related]
16. Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis.
van Erning FN; Mackay TM; van der Geest LGM; Groot Koerkamp B; van Laarhoven HWM; Bonsing BA; Wilmink JW; van Santvoort HC; de Vos-Geelen J; van Eijck CHJ; Busch OR; Lemmens VE; Besselink MG;
Acta Oncol; 2018 Dec; 57(12):1655-1662. PubMed ID: 30264642
[TBL] [Abstract][Full Text] [Related]
17. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.
Bergeat D; Turrini O; Courtin-Tanguy L; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
Langenbecks Arch Surg; 2018 Sep; 403(6):701-709. PubMed ID: 30112638
[TBL] [Abstract][Full Text] [Related]
18. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
[TBL] [Abstract][Full Text] [Related]
19. The Surgical Apgar Score Is an Independent Prognostic Factor in Patients with Pancreatic Cancer Undergoing Pancreatoduodenectomy Followed by Adjuvant Chemotherapy.
Aoyama T; Kazama K; Murakawa M; Atsumi Y; Shiozawa M; Kobayashi S; Ueno M; Morimoto M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
Anticancer Res; 2016 May; 36(5):2497-503. PubMed ID: 27127164
[TBL] [Abstract][Full Text] [Related]
20. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
